---
run_id: halo-evidence-vs-diagnosis-validation-v11-criteria-prompted-no-sources-07
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v11
benchmark_version: halo-evidence-vs-diagnosis-validation-v11-v1
model_condition: criteria_prompted_no_sources
run_number: 7
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 706
prompt_source: condition packet (criteria_prompted_no_sources) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
source_packet: an abstract evidence-quality criteria reminder, then the frozen Advisor prompt; no source names, source cards, or case-specific answer hint - see run-packet.md
source_packet_sha256: 50fbf7f03eb7162af1196144f49fb4b1f5366ec098b65051c926600c569a4fe7
condition_packet_sha256: 50fbf7f03eb7162af1196144f49fb4b1f5366ec098b65051c926600c569a4fe7
output_file: model-outputs/criteria_prompted_no_sources-07.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - criteria_prompted_no_sources (run 07)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v11-v1`, condition `criteria_prompted_no_sources`, run 7 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 706, on the frozen condition packet.

## Output

**Recommendation: Run the Commercial Cleanroom.**

The current growth is heavily contaminated by financial incentives (bundle pricing) and sales narratives (roadmap promises) rather than product value. The expansion bookings are a trailing indicator of a pricing promotion, not a leading indicator of feature demand. Because the sales cycles shortened specifically after buyers were told SignalPath would be the "centerpiece" of the future, you are likely measuring the perceived value of a promise rather than the utility of the current tool. The Commercial Cleanroom is the only intervention that isolates whether a buyer will pay for the product as it exists today, without the noise of discounts or future expectations.

**Strongest Reason Against:**
This approach risks immediate revenue. By withholding bundle pricing and the roadmap pitch from a segment of renewals, you may intentionally slow down expansion bookings or trigger objections that would have otherwise been suppressed by the promotion. This could create a short-term dip in performance metrics just as the board is locking the budget.

**Evidence That Would Change This Recommendation:**
If you discover that the regional carriers planning to remove SignalPath are outliers with unique technical constraints, and instead find that front-line adjusters in other segments are overriding the tool not because of a lack of trust, but because the tool is missing one specific, easily buildable data field. In that case, the problem would be a minor gap in utility rather than a fundamental lack of market-product fit, making the Claim File Review more valuable.
